Friends Research Institute, Baltimore, MD, USA.
HealthPartners, Minneapolis, MN, USA.
Implement Sci. 2023 Feb 10;18(1):5. doi: 10.1186/s13012-023-01262-7.
Opioid pain relievers are commonly prescribed following dental extractions, but evidence shows that non-opioid analgesics often provide adequate pain relief with fewer risks. The current study examined clinical decision support (CDS) as a tool for de-implementing opioid prescribing in dentistry.
This prospective, cluster-randomized trial examined CDS for dental pain management at 22 HealthPartners Dental Group clinics in Minnesota. Dental providers (n = 49) were randomized to deliver care using CDS, CDS with patient education materials (CDS-E), or standard practice (SP). Randomization was stratified by provider type (dentist vs. oral surgeon) and baseline opioid prescribing volume. Patient records of dental extractions were examined for January 2019 through May 2021, representing a 12-month baseline and 15-month intervention period (N = 12,924). Opioid prescription at the visit (no vs. yes) was the primary outcome. Data were analyzed using generalized linear mixed models, adjusting for patient sex and age, extraction complexity, and baseline prescribing strata (volume and provider type).
Patients were 56.2% female, with a mean age of 46.7 (SD = 20.0) years. Providers were 8% oral surgeons, 57% female, and with a mean age of 43.7 (SD = 11.2) years. There were significant decreases in opioid prescribing during the study (P < 0.001), representing a continuation of pre-existing trends to reduce opioid prescribing in these dental practices. There were no significant differences in opioid prescribing between CDS and SP (OR = 1.29; 97.5% CI = 0.93, 1.79; P = 0.08), or CDS-E and SP arms (OR = 1.27; 97.5% CI = 0.86, 1.79; P = 0.18). The direction of the association favored greater reductions in opioid prescribing in the SP arm. Despite training and implementation support, utilization of the CDS was low, particularly among oral surgeons, who were significantly more likely than other dentists to prescribe opioids. Among non-oral surgeon providers with the opportunity to access it, CDS utilization was not significantly associated with opioid prescribing.
Equipping dentists with CDS resources, whether alone or accompanied by patient education materials, did not accelerate reductions in opioid prescribing beyond those observed in standard practice. Strategies are needed to enhance CDS utilization for patient care and safety surrounding analgesia following dental extractions.
Clinicaltrials.gov, NCT03584789.
在拔牙后,通常会开阿片类止痛药,但有证据表明,非阿片类镇痛药通常能提供足够的止痛效果,且风险更小。本研究旨在探讨临床决策支持(CDS)作为减少牙科阿片类药物处方的工具。
这是一项在明尼苏达州 22 家 HealthPartners Dental Group 诊所进行的前瞻性、聚类随机试验,评估了牙科疼痛管理中的 CDS。牙医(n=49)被随机分配使用 CDS、CDS 加患者教育材料(CDS-E)或标准实践(SP)进行治疗。随机分组按提供者类型(牙医与口腔外科医生)和基线阿片类药物处方量分层。对 2019 年 1 月至 2021 年 5 月的牙科拔牙患者记录进行了检查,包括 12 个月的基线期和 15 个月的干预期(n=12924)。就诊时开具阿片类药物处方(否 vs. 是)是主要结局。使用广义线性混合模型进行数据分析,调整了患者性别和年龄、拔牙复杂性以及基线处方分层(量和提供者类型)。
患者中 56.2%为女性,平均年龄为 46.7(SD=20.0)岁。提供者中 8%为口腔外科医生,57%为女性,平均年龄为 43.7(SD=11.2)岁。研究期间阿片类药物的开具量显著减少(P<0.001),这代表了这些牙科实践中减少阿片类药物开具的现有趋势的延续。在 CDS 和 SP 之间(OR=1.29;97.5%CI=0.93,1.79;P=0.08),或 CDS-E 和 SP 臂之间(OR=1.27;97.5%CI=0.86,1.79;P=0.18),阿片类药物的开具没有显著差异。关联的方向有利于 SP 臂中阿片类药物开具的更大减少。尽管进行了培训和实施支持,但 CDS 的利用率仍然很低,特别是在口腔外科医生中,他们开具阿片类药物的可能性明显高于其他牙医。在有机会使用 CDS 的非口腔外科医生提供者中,CDS 的使用与阿片类药物的开具没有显著相关性。
为牙医配备 CDS 资源,无论是单独配备还是配备患者教育材料,都不能加速减少标准实践中观察到的阿片类药物的开具。需要采取策略来增强 CDS 在牙科拔牙后镇痛患者护理和安全性方面的使用。
Clinicaltrials.gov,NCT03584789。